Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT00214318
Eligibility Criteria:
Inclusion Criteria:
* systolic dysfunction with ejection fraction ≤40%
* symptomatic heart failure class 2-3
* \>18 years of age
* optimal medical therapy of HF excluding the use of any beta-blockers within the previous 30 days of the study
Exclusion Criteria:
* active myocarditis
* hemodynamically significant valvular heart disease
* hypertrophic cardiomyopathy
* contra-indications to beta-blockers
* concomitant use of beta-agonists
* beta-antagonist or anti-arrhythmics
* unstable angina
* myocardial infarction or bypass surgery within 3 months
* significant renal insufficiency \[creatinine \>2.5 mg/dL\], liver disease, or anemia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00214318
Study Brief:
Protocol Section:
NCT00214318